Ryan's Feed
Oct 2, 2014

Futures flat after extended equity weakness

NEW YORK, Oct 2 (Reuters) – U.S. stock index futures were
little changed on Thursday, following a sharp drop in the
previous session as investors looked to upcoming economic data
for trading incentives.

* Equities have been weak of late, with the S&P 500 down for
seven of the past nine sessions, and closing under its 100-day
moving average for the first time since Aug. 7 on Wednesday.

Oct 1, 2014

Wall St falls 1 pct on Ebola fears

NEW YORK, Oct 1 (Reuters) – U.S. stocks fell 1 percent on
Wednesday as the first diagnosis of Ebola in a patient in the
United States spooked investors and pressured shares of airlines
and other transportation-related shares.

The day’s losses were broad, with nine of the ten primary
S&P 500 sectors falling. Declining issues outnumbered advancing
ones on the NYSE by 2,161 to 863, for a 2.50-to-1 ratio; on the
Nasdaq, 2,064 issues were lower and 576 higher for a 3.58-to-1
ratio.

Oct 1, 2014

Utilities rally as day’s sole positive sector

NEW YORK, Oct 1 (Reuters) – Utility shares rallied
on Wednesday, the only one of the ten primary S&P 500 sectors in
positive territory, as investors sought protection amid
uncertainty over the first patient to be diagnosed with Ebola in
the United States.

The group, considered a defensive play for its high yields,
rose 1.3 percent on high volume, led by Exelon Corp,
which added 3.4 percent to $35.26, and NRG Energy, up
2.7 percent to $21.30. Both stocks were on track to outpace
their 50-day average volume.

Oct 1, 2014

BofA measure of bullishness implies 19 pct gain for S&P

NEW YORK, Oct 1 (Reuters) – A measure of Wall Street
bullishness rose in September, during a month when the S&P 500
hit record levels, but optimism is not so high that markets have
become complacent, Bank of America-Merrill Lynch wrote on
Wednesday.

The firm’s Sell Side Indicator rose from 51.1 in August to
51.8, a five-month high, below what the firm considers “sell”
territory.

Oct 1, 2014

Wall St dips; VIX level suggests market may be oversold

NEW YORK, Oct 1 (Reuters) – U.S. stocks fell on Wednesday,
with investors spooked by the first diagnosis of Ebola in a
patient in the United States, but the CBOE Volatility index
pared back from earlier gains, suggesting further
volatility may be limited.

The VIX, a measure of investor anxiety, rose as much as 7.6
percent on Wednesday, nearing its highest since April, before it
shed most of those gains. It last traded up 2.3 percent at
16.69, still well below its long-term average of 20.

Oct 1, 2014

Wall St falls on Ebola concerns; airlines tumble

NEW YORK, Oct 1 (Reuters) – U.S. stocks were lower on
Wednesday as caution rose following the first diagnosis of a
patient in the United States with Ebola.

Airline stocks fell sharply on concerns the disease could
curb air travel, with several numbering among the biggest
decliners on the S&P 500. Delta Air Lines lost 3.5
percent to $34.90 while Southwest Airlines was off 2.8
percent at $32.83. The NYSE Arca Airline index fell 2.1
percent.

Oct 1, 2014

Futures point to lower open on Ebola concerns

NEW YORK, Oct 1 (Reuters) – U.S. stock index futures pointed
to a lower open on Wednesday, as caution arose following the
first diagnosis of a patient in the United States with Ebola.

While drug companies with Ebola treatments in their
pipelines rallied in heavy trading, the news gave investors a
reason to sell, with major indexes near record levels. Airline
shares were lower on concerns the disease could curb travel.

Oct 1, 2014

Options market is underpricing earnings moves -Goldman

NEW YORK, Oct 1 (Reuters) – U.S. stock market volatility has
been higher of late – the CBOE Volatility index spiked 36
percent in September – but the options market is “nearly missing
the potential” for stocks to move following their earnings,
Goldman Sachs wrote on Wednesday.

The firm said the options market was implying an earnings
move of 3.3 percent for the earliest companies to report, “the
lowest level over the past 10 years, and 1 percent lower than
the current realized environment suggests.”

Oct 1, 2014

Ebola diagnosis in U.S. drives premarket movers

NEW YORK, Oct 1 (Reuters) – Biotechnology companies with
Ebola drugs were among the most active premarket movers on
Wednesday, following the first diagnosis of a patient in the
U.S. with the disease.

The shares rallied on concerns the disease could be
spreading, while a number of airline stocks were weaker on
concerns the disease could curb travel.

Oct 1, 2014

Stock futures begin fourth quarter flat, data awaited

NEW YORK (Reuters) – U.S. stock index futures were little changed on Wednesday as investors looked ahead to a number of economic reports that could set the tone for the fourth quarter on Wall Street.

* Markets are coming off a positive third quarter with a seventh straight quarterly gain for both the S&P 500 and Nasdaq, but also a decline for major indexes in September.